![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
2028年までの北米脳腫瘍診断市場予測 - 新型コロナウイルス感染症の影響と診断タイプ別の地域分析(画像検査、腰椎穿刺、生検、分子検査など)。がんの種類(聴神経腫、星状細胞腫、頭蓋咽頭腫、神経節神経腫、多形膠芽腫、髄膜腫、上衣腫など);エンドユーザー (病院、専門クリニック、外来手術センターなど)
市場紹介
脳がんは、腫瘍を引き起こす脳内の細胞の細胞外増殖によって引き起こされます。腫瘍には原発性脳腫瘍と続発性脳腫瘍が含まれます。原発性脳腫瘍は脳内で形成され、体の他の部分には広がりませんが、二次腫瘍(転移とも呼ばれます)は体の別の部分で発生したがんです。 脳腫瘍は 40 の主要なタイプに分類され、さらに 2 つの主要なグループに分類されます。1 つは良性、つまり成長が遅く転移する可能性が低いもの、悪性、つまり癌性で転移する可能性が高いものです。
< p>したがって、脳腫瘍の有病率の増加により、今後数年間で脳腫瘍診断に対する大きな需要が生み出されると予想され、それが脳腫瘍診断市場をさらに牽引すると予想されます。新型コロナウイルス感染症(COVID-19)パンデミックは医療システムを混乱させ、その後の新型コロナウイルス以外の疾患への影響が懸念されています。がんの診断と治療は一刻を争うものであり、これらの症状によって大きな影響を受ける可能性があります。新型コロナウイルス感染症のパンデミックにより、各がん専門分野の活動が悪影響を受けています。また、小児悪性脳腫瘍は急速に増殖する特徴があり、早期診断と適切な治療が必要です。したがって、治療を遅らせたり変更したりすると、その有効性が損なわれ、患者の生存率が低下する可能性があります。フローレスら。脳腫瘍の診断が遅れると予後の悪化と相関があると報告されました。診断前の症状が現れる間隔が長くなると、頭蓋内圧の上昇に伴う死亡や重篤な脳損傷など、否定的で重篤な結果が生じます。 SARS CoV2 感染の恐怖とプレッシャーにより、脳腫瘍を持つ子どもたちの意思決定プロセスの変化は、最終的な転帰に悪影響を与える可能性があります。現在の新型コロナウイルス感染症の流行中、学際的な腫瘍委員会が重要な役割を果たしたことは一度もありません。新たな脳腫瘍と診断されたすべての小児症例は、学際的な腫瘍委員会で議論され、各小児にとって最適な治療計画が決定される必要があります。
市場の概要とダイナミクス
北米の脳腫瘍診断市場は、3億150万米ドルから成長すると予想されています。 2021年から2028年までに9億1,100万米ドルへ。 2021 年から 2028 年まで CAGR 17.1% で成長すると推定されています。研究者らは、人工知能技術と病理医が相互に検証できる能力は、病理医が人工知能技術と協力して困難な症例を解釈し、確実な診断を行う必要性を浮き彫りにしていると指摘しました。可能な限り最高の診断精度。現在、米国のいくつかの主要ながんセンターが SRH イメージャーを使用しています。 SRH と AI イメージングはどちらも新興テクノロジーであるため、ヘルスケアに統合するのは困難です。 AI テクノロジーにより、外科医は腫瘍や健康な組織を含む領域を迅速かつ正確に特定できるようになります。このため、手術中の脳腫瘍診断を強化するために SRH 人工知能の使用が増えています。
主要市場セグメント
診断の種類に関しては、画像検査セグメントが 2020 年の北米脳腫瘍診断市場で最大のシェアを占めました。癌の種類に関しては、多形神経膠芽腫セグメントが最大のシェアを占めました。 2020 年の北米脳腫瘍診断市場のシェア。エンドユーザーの観点から見ると、2020 年の北米脳腫瘍診断市場で病院セグメントが最大のシェアを占めました。
リストされている主要な情報源と企業
いくつかの主要な一次情報源と二次情報源北米の脳腫瘍診断市場に関するこのレポートを作成するために参照したのは、企業の Web サイト、年次報告書、財務報告書、政府文書、統計データベースなどです。このレポートに記載されている主要企業は、Thermo Fisher Scientific Inc.、Siemens Healthineers A、GE Healthcare、MDxHealth、NantOmics、Biocept, Inc.、Koninklijke Philips NV、Canon Medical Systems、Hitachi, Ltd.、Neusoft Medical Systems です。
レポートを購入する理由
- 北米の脳腫瘍診断市場の状況を理解し、最も重要な市場セグメントを特定するため。大きな利益が保証される可能性が高い
- 北米脳腫瘍診断市場の絶え間なく変化する競争環境を理解し、競争に先んじる
- 北米でのM&Aおよびパートナーシップ取引を効率的に計画する最も売上が見込まれる市場セグメントを特定することにより、アメリカ脳腫瘍診断市場
- 北米脳腫瘍診断市場のさまざまなセグメントの市場パフォーマンスの知覚的かつ包括的な分析から、知識に基づいたビジネス上の意思決定を行うのに役立ちます
- 北米地域の 2021 年から 2028 年までのさまざまなセグメント別の市場収益予測を取得します。
北米脳腫瘍診断市場セグメンテーション
診断タイプ別
< ul>- MRI
- CT スキャン
- PET
がんの種類別
- 多形膠芽腫
- 星状細胞腫
- 上衣腫
- その他
作成者 エンド ユーザー
- 病院
- 専門クリニック
- 外来手術センター
- その他
国別
- 北米
- 米国
- カナダ
- メキシコ
記載されている企業
- Thermo Fisher Scientific Inc.
- Siemens Healthineers A
- GE Healthcare
- MDxHealth
- NantOmics
- Biocept, Inc.
- Koninklijke Philips NV
- Canon Medical Systems
- 株式会社日立製作所
- Neusoft Medical Systems
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Brain Cancer Diagnostics Market – By Diagnostic Type
1.3.2 Brain Cancer Diagnostics Market – By Cancer Type
1.3.3 Brain Cancer Diagnostics Market – By End User
1.3.4 North America Brain Cancer Diagnostics Market – By Country
2. North America Brain Cancer Diagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Brain Cancer Diagnostics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Brain Cancer Diagnostics Market- North America PEST Analysis
4.3 Expert Opinion
5. North America Brain Cancer Diagnostics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Prevalence of Brain Cancer
5.1.2 Rise in Number of Cigarette Smokers
5.2 Market Restraints
5.2.1 High Cost of Diagnosis
5.3 Future Trends
5.3.1 Use of Stimulated Raman Histology (SRH)?Artificial Intelligence (AI) to Enhance Brain Tumor Diagnosis During Surgery
5.4 Impact Analysis
6. Brain Cancer Diagnostics Market – North America Analysis
6.1 North America Brain Cancer Diagnostics Market Revenue Forecasts and Analysis
7. North America Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Diagnostic Type
7.1 Overview
7.2 Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)
7.3 Imaging Tests
7.3.1 Overview
7.3.2 Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 MRI
7.3.3.1 Overview
7.3.3.2 MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 CT Scan
7.3.4.1 Overview
7.3.4.2 CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Positron emission tomography (PET)
7.3.5.1 Overview
7.3.5.2 Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Lumbar Puncture
7.4.1 Overview
7.4.2 Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Biopsy
7.5.1 Overview
7.5.2 Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Molecular Testing
7.6.1 Overview
7.6.2 Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8. North America Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Cancer Type
8.1 Overview
8.2 Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)
8.3 Astrocytomas
8.3.1 Overview
8.3.2 Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Glioblastoma Multiforme
8.4.1 Overview
8.4.2 Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Ependymomas
8.5.1 Overview
8.5.2 Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9. Brain Cancer Diagnostics Market Analysis – By End user
9.1 Overview
9.2 Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Specialty Clinics
9.4.1 Overview
9.4.2 Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Ambulatory Surgical Centers
9.5.1 Overview
9.5.2 Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10. Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 – Geographical Analysis
10.1 North America: Brain Cancer Diagnostics Market
10.1.1 Overview
10.1.2 North America: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
10.1.3 US: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.3.1 US: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.3.2 US Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)
10.1.3.2.1 US Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
10.1.3.3 US Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
10.1.3.4 US Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.4 Canada: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.4.1 Canada: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.4.2 Canada Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)
10.1.4.2.1 Canada Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
10.1.4.3 Canada Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
10.1.4.4 Canada Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.5 Mexico: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.5.1 Mexico: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.5.2 Mexico Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)
10.1.5.2.1 Mexico Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
10.1.5.3 Mexico Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
10.1.5.4 Mexico Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11. Impact Of COVID-19 Pandemic on North America Brain Cancer Diagnostics Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.1 Organic Developments
12.1.1 Overview
12.2 Inorganic Developments
12.2.1 Overview
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Siemens Healthineers AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 GE Healthcare
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 MDxHealth
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 NantOmics
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Biocept, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Koninklijke Philips N.V.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Canon Medical Systems
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Hitachi, Ltd.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Neusoft Medical Systems
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. US Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)
Table 2. US Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
Table 3. US Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
Table 4. US Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 5. Canada Brain Cancer Diagnostics Market, by Diagnostic Type - Revenue and Forecast to 2028 (USD Million)
Table 6. Canada Brain Cancer Diagnostics Market, by Imaging Test - Revenue and Forecast to 2028 (USD Million)
Table 7. Canada Brain Cancer Diagnostics Market, by Cancer Type - Revenue and Forecast to 2028 (USD Million)
Table 8. Canada Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 9. Mexico Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)
Table 10. Mexico Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
Table 11. Mexico Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
Table 12. Mexico Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 13. Organic Developments in the Brain Cancer Diagnostics Market
Table 14. Inorganic Developments in the Brain Cancer Diagnostics Market
Table 15. Glossary of Terms, Brain Cancer Diagnostics Market
LIST OF FIGURES
Figure 1. Brain Cancer Diagnostics Market Segmentation
Figure 2. North America Brain Cancer Diagnostics Market Overview
Figure 3. Imaging Test Segment Held Largest Share of Diagnostic Type in Brain Cancer Diagnostics Market
Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Brain Cancer Diagnostics Market - North America PEST Analysis
Figure 6. Brain Cancer Diagnostics Market Impact Analysis of Driver and Restraints
Figure 7. North America Brain cancer diagnostics Market – Revenue Forecasts and Analysis – 2020- 2028
Figure 8. Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)
Figure 9. Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)
Figure 18. Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)
Figure 23. Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. North America: Brain Cancer Diagnostics Market, by Key Country – Revenue (2021) (USD Million)
Figure 28. North America: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 29. US: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 30. Canada: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 31. Mexico: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Impact of COVID-19 Pandemic in North American Country Markets
Figure 33. Growth Strategies Done by the Companies in the Market, (%)
- Thermo Fisher Scientific Inc.
- Siemens Healthineers A
- GE Healthcare
- MDxHealth
- NantOmics
- Biocept, Inc.
- Koninklijke Philips N.V
- Canon Medical Systems
- Hitachi, Ltd.
- Neusoft Medical Systems
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America brain cancer diagnostics market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America brain cancer diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the brain cancer diagnostics market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution